The British Journal of Clinical Pharmacy
— Volume 2, Issue 3, March 2010
To download the complete issue, please select one of the following formats:
Article Title
The British Pain Society has recently updated its guidance on the use of opioids in persistent pain. This article describes some of the key changes, including updated information about long-term opioid use. By Shona Kirk.
More than 3,500 patients per year now receive donated organs in the UK.  Survival of patients depends not only on the new organ but also on transplantation drugs. Caroline Ashley discusses the challenges and treatment options, with particular reference to kidney transplants.
Prescriber’s Corner describes situations encountered by pharmacist prescribers and invites you to consider clinical decisions about the patient. In this case you are advising on a drug regimen for a patient showing signs of an adverse reaction to tuberculosis therapy. By Adam Todd, Alan Worsley and Andrew Husband.
The risks of bleeding associated with therapy for non-ST elevation acute coronary syndrome are becoming clear. This article describes why it is important to prescribe the correct dose of anti-ischaemic therapy to minimise these risks. By Sotiris Antoniou.
By Sam Coffey, Monsey McLeod and Bryony Dean Franklin.
Information about recent sales and future research and development prospects of the major pharmaceutical companies can be found in their annual reports. This article reviews the recent report by Roche, to illustrate the issues that are of relevance to clinical pharmacists. By Philip Brown.
To ensure that our profession is truely patient-focused, wider adoption of technology such as robotic dispensing is required, says Philip Brown.